Washington Trust Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.7K | Hold |
778
| – | – | ﹤0.01% | 317 |
|
|
2025
Q1 | $54K | Buy |
778
+260
| +50% | +$18.1K | ﹤0.01% | 316 |
|
|
2024
Q4 | $44.6K | Sell |
518
-6
| -1% | -$516 | ﹤0.01% | 338 |
|
|
2024
Q3 | $62.4K | Hold |
524
| – | – | 0.01% | 300 |
|
|
2024
Q2 | $74.8K | Hold |
524
| – | – | 0.01% | 274 |
|
|
2024
Q1 | $67.3K | Hold |
524
| – | – | 0.01% | 280 |
|
|
2023
Q4 | $54.2K | Hold |
524
| – | – | 0.01% | 298 |
|
|
2023
Q3 | $47.7K | Hold |
524
| – | – | ﹤0.01% | 308 |
|
|
2023
Q2 | $42.4K | Buy |
524
+2
| +0.4% | +$162 | ﹤0.01% | 311 |
|
|
2023
Q1 | $41.5K | Sell |
522
-14
| -3% | -$1.11K | ﹤0.01% | 332 |
|
|
2022
Q4 | $36.3K | Sell |
536
-1,856
| -78% | -$126K | ﹤0.01% | 345 |
|
|
2022
Q3 | $119K | Buy |
2,392
+820
| +52% | +$40.8K | 0.01% | 251 |
|
|
2022
Q2 | $88K | Buy |
1,572
+86
| +6% | +$4.81K | 0.01% | 313 |
|
|
2022
Q1 | $83K | Sell |
1,486
-70
| -4% | -$3.91K | 0.01% | 363 |
|
|
2021
Q4 | $88K | Buy |
+1,556
| New | +$88K | 0.01% | 382 |
|